ShangPharma Innovation | Dirk Brockstedt, Ph.D.
team_member-template-default,single,single-team_member,postid-15875,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,qode-content-sidebar-responsive,qode-theme-ver-10.1.1,builder-parallax-scrolling-active,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Dirk Brockstedt, Ph.D.

Dr. Brockstedt is executive vice president of research and development for Aduro Biotech, an immunotherapy company. Prior to joining Aduro in 2009, he held various positions at Cerus Corp., where he was a foundational member of the original immunotherapy group. Dr. Brockstedt previously served as a scientist at Aventis, where he developed novel cancer therapies. He has co-authored 40 scientific papers and is a named inventor on five issued patents and several pending applications. He holds a degree in microbiology from the University of Kiel in Germany and completed doctoral and postdoctoral work at Stanford University and the Stanford School of Medicine.